Key Takeaway: BioMarin Pharmaceutical Inc. has announced its participation in upcoming investor conferences in September. Management will present, and an audio webcast will be available live, with an archived version accessible later. The company emphasizes its commitment to developing innovative therapies for rare genetic conditions.
Price reaction · baseline $57.45 (2025-08-26 close) · hit pre-market · 1 other BMRN headline(s) in the window, move may be shared
day 0 close · peak
+2.1%
Market Sentiment Analysis
POSITIVE FACTORS
BioMarin is actively engaging with investors through presentations.
The company has a strong track record of innovation.
BioMarin is dedicated to developing treatments for rare genetic conditions.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+25%
120-day peak, hindsight
Typical move
7.9%
average across 8 past catalysts
Lead asset
Valoctocogene roxaparvovec
Phase 3 · Hemophilia A
Full Press Release Details
SAN RAFAEL, Calif.,Aug. 27, 2025/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that management will present at upcoming investor conferencesin September.
An audio webcast of the presentation will be available live. You can access the webcast at:https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael,California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visitwww.biomarin.com.
Contacts:
Investors
Media
Traci McCarty
Marni Kottle
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(650) 374-2803
Frequently Asked Questions
When will BioMarin present at investor conferences?
BioMarin will present at upcoming investor conferences in September.
How can I access the BioMarin presentations?
The presentations will be available via a live audio webcast on their website.
What is BioMarin known for?
BioMarin is known for developing innovative therapies for rare genetic conditions.